- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
Cannabinoids in the Treatment of Parkinson’s Disease ; volume:01 ; number:04 ; year:2017 ; pages:E307-E311
Neurology international open ; 01, Heft 04 (2017), E307-E311
- Contributor
- DOI
-
10.1055/s-0043-115359
- URN
-
urn:nbn:de:101:1-2019070510130186128076
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:55 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Gandor, Florin
- Ebersbach, Georg
Other Objects (12)
Pharmacological treatment of Parkinson’s disease
The treatment of advanced Parkinson's disease
Adenosine A2A receptors in Parkinson’s disease treatment
Off-time Treatment Options for Parkinson’s Disease
Treatment Options for Urogenital Dysfunction in Parkinson’s Disease
Frankincense: A neuronutrient to approach Parkinson’s disease treatment
The heterogeneity of Parkinson’s disease
The immunology of Parkinson’s disease
Hypoxia treatment of Parkinson’s disease may disrupt the circadian system
Benefits of Iron Chelators in the Treatment of Parkinson’s Disease
How to optimize the treatment of early stage Parkinson’s disease
Drugs for the treatment of Parkinson's disease
Pharmacological treatment of Parkinson’s disease
The treatment of advanced Parkinson's disease
Adenosine A2A receptors in Parkinson’s disease treatment
Off-time Treatment Options for Parkinson’s Disease
Treatment Options for Urogenital Dysfunction in Parkinson’s Disease
Frankincense: A neuronutrient to approach Parkinson’s disease treatment
The heterogeneity of Parkinson’s disease
The immunology of Parkinson’s disease
Hypoxia treatment of Parkinson’s disease may disrupt the circadian system
Benefits of Iron Chelators in the Treatment of Parkinson’s Disease
How to optimize the treatment of early stage Parkinson’s disease
Drugs for the treatment of Parkinson's disease
Pharmacological treatment of Parkinson’s disease
The treatment of advanced Parkinson's disease
Adenosine A2A receptors in Parkinson’s disease treatment
Off-time Treatment Options for Parkinson’s Disease
Treatment Options for Urogenital Dysfunction in Parkinson’s Disease
Frankincense: A neuronutrient to approach Parkinson’s disease treatment
The heterogeneity of Parkinson’s disease
The immunology of Parkinson’s disease
Hypoxia treatment of Parkinson’s disease may disrupt the circadian system
Benefits of Iron Chelators in the Treatment of Parkinson’s Disease
How to optimize the treatment of early stage Parkinson’s disease